Počet záznamov: 1
Epigenetic landscape in pancreatic ductal adenocarcinoma: on the way to overcoming drug resistance?
Názov Epigenetic landscape in pancreatic ductal adenocarcinoma: on the way to overcoming drug resistance? Autor Čierniková Soňa 1978- SAVBIOMED ; SAVEXONK - Biomedicínske centrum SAV SCOPUS RID ORCID Spoluautori Earl Julie Garcia Bermejo Maria Laura Števurková Viola SAVEXONK ; SAVBIOMED - Ústav experimentálnej onkológie SAV Carrato Alfredo Smolková Božena 1968- SAVBIOMED ; SAVEXONK - Biomedicínske centrum SAV SCOPUS RID ORCID Zdroj.dok. International Journal of Molecular Sciences. Vol. 21, no. 11 (2020), art.no. 4091 Jazyk dok. eng - angličtina Poznámky open access URL URL link Druh dok. rozpis článkov z periodík (rbx) Ohlasy STRAPCOVA, S. - TAKACOVA, M. - CSADEROVA, L. - MARTINELLI, P. - LUKACIKOVA, L. - GAL, V. - KOPACEK, J. - SVASTOVA, E. Clinical and Pre-Clinical Evidence of Carbonic Anhydrase IX in Pancreatic Cancer and Its High Expression in Pre-Cancerous Lesions. In CANCERS. AUG 2020, vol. 12, no. 8. SANKARASUBRAMANIAN, S. - PFOHL, U. - REGENBRECHT, C.R.A. - REINHARD, C. - WEDEKEN, L. Context Matters-Why We Need to Change From a One Size Fits all Approach to Made-to-Measure Therapies for Individual Patients With Pancreatic Cancer. In FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY. ISSN 2296-634X, NOV 4 2021, vol. 9. HEUMANN, T. - AZAD, N. Next-generation immunotherapy for pancreatic ductal adenocarcinoma: navigating pathways of immune resistance. In CANCER AND METASTASIS REVIEWS. ISSN 0167-7659, SEP 2021, vol. 40, no. 3, SI, p. 837-862. THAKUR, G. - KUMAR, R. - KIM, S.B. - LEE, S.Y. - LEE, S.L. - RHO, G.J. Therapeutic Status and Available Strategies in Pancreatic Ductal Adenocarcinoma. In BIOMEDICINES. FEB 2021, vol. 9, no. 2. GAO, F.Y. - WANG, Q.Q. - ZHANG, C. - ZHANG, C. - QU, T.Y. - ZHANG, J.Y. - WEI, J.F. - GUO, R.H. RNA methyltransferase METTL3 induces intrinsic resistance to gefitinib by combining with MET to regulate PI3K/AKT pathway in lung adenocarcinoma. In JOURNAL OF CELLULAR AND MOLECULAR MEDICINE. ISSN 1582-1838, MAR 2021, vol. 25, no. 5, p. 2418-2425. HEUMANN, T.R. - BARETTI, M. - SUGAR, E.A. - DURHAM, J.N. - LINDEN, S. - LOPEZ-VIDAL, T.Y. - LEATHERMAN, J. - COPE, L. - SHARMA, A. - WEEKES, C.D. - O'DWYER, P.J. - REISS, K.A. - MONGA, D.K. - AHUJA, N. - AZAD, N.S. A randomized, phase II trial of oral azacitidine (CC-486) in patients with resected pancreatic adenocarcinoma at high risk for recurrence. In CLINICAL EPIGENETICS. ISSN 1868-7075, DEC 2022, vol. 14, no. 1. Dostupné na: https://doi.org/10.1186/s13148-022-01367-8. ARUL, G.L.R. - TORUNER, M.D. - GATENBY, R.A. - CARR, R.M. Ecoevolutionary biology of pancreatic ductal adenocarcinoma. In PANCREATOLOGY. ISSN 1424-3903, SEP 2022, vol. 22, no. 6, p. 730-740. Dostupné na: https://doi.org/10.1016/j.pan.2022.06.005. MAIETTA, I. - MARTINEZ-PEREZ, A. - ALVAREZ, R. - DE LERA, A.R. - GONZALEZ-FERNANDEZ, A. - SIMON-VAZQUEZ, R. Synergistic Antitumoral Effect of Epigenetic Inhibitors and Gemcitabine in Pancreatic Cancer Cells. In PHARMACEUTICALS. JUL 2022, vol. 15, no. 7. Dostupné na: https://doi.org/10.3390/ph15070824. TAN, P. - LI, M. - LIU, Z.R. - LI, T.X. - ZHAO, L.Y. - FU, W.G. Glycolysis-Related LINC02432/Hsa-miR-98-5p/HK2 Axis Inhibits Ferroptosis and Predicts Immune Infiltration, Tumor Mutation Burden, and Drug Sensitivity in Pancreatic Adenocarcinoma. In FRONTIERS IN PHARMACOLOGY. JUN 20 2022, vol. 13. Dostupné na: https://doi.org/10.3389/fphar.2022.937413. POPOV, A. - MANDYS, V. Senescence-Associated miRNAs and Their Role in Pancreatic Cancer. In PATHOLOGY & ONCOLOGY RESEARCH. ISSN 1219-4956, APR 29 2022, vol. 28. Dostupné na: https://doi.org/10.3389/pore.2022.1610156. MALHOTRA, P. - PALANISAMY, R. - FALASCA, M. Targeting pancreatic ductal adenocarcinoma: New therapeutic options for the ongoing battle. In HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL. ISSN 1499-3872, FEB 2022, vol. 21, no. 1, p. 4-6. Dostupné na: https://doi.org/10.1016/j.hbpd.2021.09.004. LIU, X.H. - ZHANG, X.F. - DU, S.Z. Long non-coding RNA ACTA2-AS1 inhibits the cisplatin resistance of non-small cell lung cancer cells through inhibiting autophagy by suppressing TSC2. In CELL CYCLE. ISSN 1538-4101, FEB 16 2022, vol. 21, no. 4, p. 368-378. Dostupné na: https://doi.org/10.1080/15384101.2021.2020433. Kategória ADCA - Vedecké práce v zahraničných karentovaných časopisoch impaktovaných Kategória (od 2022) V3 - Vedecký výstup publikačnej činnosti z časopisu Typ výstupu článok Rok vykazovania 2020 Registrované v WOS Registrované v SCOPUS Registrované v CCC DOI 10.3390/ijms21114091 
článok
Názov súboru Prístup Veľkosť Stiahnuté Typ Licence Epigenetic landscape in pancreatic ductal adenocarcinoma on the way to overcoming drug resistance.pdf Prístupný 2.9 MB 2 Vydavateľská verzia rok CC IF IF Q (best) JCR Av Jour IF Perc SJR SJR Q (best) CiteScore A rok vydania rok metriky IF IF Q (best) SJR SJR Q (best) 2020 2019 4.556 Q1 1.317 Q1
Počet záznamov: 1